This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Vanderbilt University. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Macrae F Linton: Innovator in Atherosclerosis Treatment
Introduction
Macrae F Linton is a notable inventor based in Nashville, TN (US). He has made significant contributions to the field of medicine, particularly in the treatment of atherosclerosis. His innovative approach has the potential to improve patient outcomes and advance medical science.
Latest Patents
Linton holds a patent for "Methods for treating atherosclerosis with gamma-ketoaldehyde scavengers." This patent describes a method of treating atherosclerosis by administering an effective amount of a gamma-ketoaldehyde scavenging compound to patients in need. This innovative treatment could provide new hope for individuals suffering from this condition.
Career Highlights
Macrae F Linton is affiliated with Vanderbilt University, where he conducts research and develops new medical treatments. His work is characterized by a commitment to advancing healthcare through innovative solutions.
Collaborations
Linton has collaborated with esteemed colleagues such as John A Oates and Sean S Davies. These partnerships have fostered a collaborative environment that enhances the research and development of new medical therapies.
Conclusion
Macrae F Linton's contributions to the field of atherosclerosis treatment exemplify the impact of innovation in medicine. His work continues to inspire advancements that may lead to better health outcomes for patients.